Overview

Georgia's cannabis sales fell 41.6% year over year even as the state's dispensary count surged 280%, jumping from five locations to 19 in the span of a year. That paradox—more stores, far less revenue—stems partly from a unit volume decline of 52.3% that outpaced the sales drop, meaning average prices actually climbed 22.4% over the period. The result is a small-tier market where a rapidly expanding retail footprint has not yet translated into broader consumer adoption. Over a two-year window the picture is similarly stark, with sales down 43.1%. Georgia's program remains narrowly scoped: the state authorized low-THC oil for qualifying medical conditions under the 2015 Hope Act, and licensed in-state production and dispensary sales began in 2021. With limited product eligibility and no recreational framework, the market's near-term trajectory depends on whether new storefronts can pull patients away from out-of-state or unregulated...

• Top Brand: Momenta
• Top Category: Oral (75%)